Similar findings were observed in VHL-positive CAKI-1 ccRCC and A549 lung cancer (Supplementary Figure 3C), suggesting that SphK1 activity regulates HIF-2α content regardless of the presence or absence of VHL. This evidence concerns the gene SPHK1 and nonpapillary renal cell carcinoma.